je.st
news
Tag: announces approval
Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine
2016-10-07 22:05:00| Merck.com - Corporate News
Dateline City: MADISON, N.J. First Vaccine to Offer Protection Against Both Strains of Canine Influenza MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced that the U.S. Department of Agriculture has approved a license for Nobivac Canine Flu Bivalent vaccine the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8. Language: English Contact: MerckMedia:Kelly Goss, 913-558-6452 kelly.goss@merck.com orPamela Eisele, 267-305-3558 pamela.eisele@merck.com orInvestor Relations:Amy Klug, 908-740-1898 amy.klug@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
animal
approval
innovative
BP announces final investment decision approval for Tangguh project in Indonesia
2016-07-04 01:00:00| Hydrocarbons Technology
BP has announced its approval of the final investment decision (FID) for the development of the Tangguh expansion project in Indonesias Papua Barat Province.
Tags: in
final
project
decision
Pfizer Announces FDA Approval Of XELJANZ XR (tofacitinib citrate) Extended-Release Tablets, The First And Only Once-Daily Oral JAK Inhibitor Treatment For Rheumatoid Arthritis
2016-03-02 04:30:55| drugdiscoveryonline Home Page
Pfizer Inc. announced recently that the U.S. Food and Drug Administration (FDA) has approved XELJANZ XR (tofacitinib citrate) extended-release 11 mg tablets for the once-daily treatment of moderate to severe rheumatoid arthritis (RA) in patients who have had an inadequate response or intolerance to methotrexate (MTX)
Tags: treatment
approval
oral
announces
Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan
2016-01-23 07:38:52| Biotech - Topix.net
Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha Injection, the first proprotein convertase subtilisin/kexin type 9 inhibitor to be approved in Japan. Repatha is a human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol , or "bad" cholesterol, from the blood.
Tags: japan
approval
injection
announces
Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA
2016-01-17 19:50:21| Biotech - Topix.net
Novartis announced today that the US Food and Drug Administration has approved Cosentyx for two new indications - the treatment of adult patients with active ankylosing spondylitis and active psoriatic arthritis . AS and PsA are both life-long, painful and debilitating inflammatory diseases that affect the joints and/or spine.
Tags: with
treatment
adult
approval